Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP569069.RAP2pskrY44LoU1cR8f9xRbLk9oGIp3fcSE_0piIdwt4E130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP569069.RAP2pskrY44LoU1cR8f9xRbLk9oGIp3fcSE_0piIdwt4E130_assertion type Assertion NP569069.RAP2pskrY44LoU1cR8f9xRbLk9oGIp3fcSE_0piIdwt4E130_head.
- NP569069.RAP2pskrY44LoU1cR8f9xRbLk9oGIp3fcSE_0piIdwt4E130_assertion description "[Genetic variability in the multidrug resistance associated protein-1 (ABCC1/MRP1) predicts hematological toxicity in breast cancer patients receiving (neo-)adjuvant chemotherapy with 5-fluorouracil, epirubicin and cyclophosphamide (FEC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP569069.RAP2pskrY44LoU1cR8f9xRbLk9oGIp3fcSE_0piIdwt4E130_provenance.
- NP569069.RAP2pskrY44LoU1cR8f9xRbLk9oGIp3fcSE_0piIdwt4E130_assertion evidence source_evidence_literature NP569069.RAP2pskrY44LoU1cR8f9xRbLk9oGIp3fcSE_0piIdwt4E130_provenance.
- NP569069.RAP2pskrY44LoU1cR8f9xRbLk9oGIp3fcSE_0piIdwt4E130_assertion SIO_000772 23396606 NP569069.RAP2pskrY44LoU1cR8f9xRbLk9oGIp3fcSE_0piIdwt4E130_provenance.
- NP569069.RAP2pskrY44LoU1cR8f9xRbLk9oGIp3fcSE_0piIdwt4E130_assertion wasDerivedFrom befree-20150227 NP569069.RAP2pskrY44LoU1cR8f9xRbLk9oGIp3fcSE_0piIdwt4E130_provenance.
- NP569069.RAP2pskrY44LoU1cR8f9xRbLk9oGIp3fcSE_0piIdwt4E130_assertion wasGeneratedBy ECO_0000203 NP569069.RAP2pskrY44LoU1cR8f9xRbLk9oGIp3fcSE_0piIdwt4E130_provenance.